Follow the people · Insider

LP

Leonard E. Post

Insider · Director · CGON

Leonard E. Post files insider transactions with the SEC as a director of CG Oncology (CGON). We hold 6 disclosed purchases and sales filed since 8 February 2007, 5 of them in the last 90 days.

  • Files forCGON
  • Disclosed buys and sells6 in all, 5 in the last 90 days
  • Last disclosure18 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 October 202414 August 2026Director · CG Oncology (CGON)58 Form 4 lines · source: SEC Form 4
  • Filed 15 September 202011 June 2026Director · uniQure (QURE)21 Form 4 lines · source: SEC Form 4
  • Filed 1 August 20221 August 2022Director · Fulgent Genetics (FLGT)1 Form 4 line · source: SEC Form 4
  • Filed 7 February 20077 February 2007Director · Praecis Pharmaceuticals (PRCS)1 Form 4 line · source: SEC Form 4

Everything they disclosed

81 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.